Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells. Gefitinib D8 is a deuterium labeled Gefitinib.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells. Gefitinib D8 is a deuterium labeled Gefitinib. |
Targets&IC50 | Tyr1173 site (NR6wtEGFR cells):37 nM , Tyr992 site (NR6wtEGFR cells):37 nM |
Synonyms | ZD1839 D8, Gefitinib D8 |
Molecular Weight | 454.95 |
Formula | C22H24ClFN4O3 |
CAS No. | 857091-32-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gefitinib-d8 857091-32-8 Others Gefitinib-d-8 ZD1839 D8 Gefitinibd8 Gefitinib D8 inhibitor inhibit